PINK:HYPMY

Hypermarcas Adr Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy HYPMY

*Your capital is at risk

$4.22

-0.0796 (-1.85%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

HYPMY Prediction Chart

HYPMY Predictions History

Latest community submissions for HYPMY.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 6, 2019	$7.44 +8.93%	$6.83	X	91.07%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HYPMY with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT HYPERMARCAS ADR

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Perida...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by